General AML

ESH 2019 | How will targeted therapies be used in the future?

L:

The AML Global Portal were delighted to speak to Andrew Wei, The Alfred Hospital, Victoria, AU, during the European School of Hematology (ESH) Translational Research Conference on AML. We asked Andrew Wei: How will targeted therapies be used in the future? He discusses the challenges of new therapeutic options and whether these should be combined or used sequentially with careful monitoring including MRD.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!